Anti-Certolizumab Polyclonal Antibody (AF879054)

Даташит Поделиться продуктом Копировать информацию

Цена(USD): $

Спецификация:

50ug
100ug

Количество:

Свяжитесь с нами

Обзор
Изображения
Ссылки
Даташит

Обзор

Каталожный номер

AF879054

Описание

Anti-Certolizumab Polyclonal Antibody (AF879054) is a rabbit polyclonal antibody detecting Certolizumab in ELISA.

Highlights

●Affinity Purified — Minimal background and high purity for reliable results.

Применения

ELISA

Хозяинский вид

Rabbit

Изотип

IgG

Клоональность

Polyclonal

Иммуноген

Certolizumab

Цель

Certolizumab

Специфичность

The product is specific for Certolizumab. This antibody serves as an excellent positive control for Certolizumab immunogenicity (ADA) assays.

Уровень эндотоксинов

Please contact with the lab for this information.

Очистка

Purified by antigen affinity column.

Номер доступа

CAS: 428863-50-7

Форма

Liquid

Буфер хранения

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Пожалуйста, обратитесь к конкретной информации о буфере в печатной версии даташита или в индивидуальном сертификате качества (COA) для партии.

Информация об использовании продукта

Применение	Разбавление
ELISA	1:5000-1:20000
IHC	1:50-1:500
WB	1:500-1:2000

Устойчивость и хранение

The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles.

Фон

Certolizumab is a Fab fragment of a monoclonal antibody to human tumor necrosis factor alpha (TNFα) which has potent antiinflammatory activity and is used in the therapy of severe rheumatoid arthritis and inflammatory bowel disease. Antibodysystem Anti-Certolizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Certolizumab.
• Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial., PMID:37423647
• Certolizumab Pegol: A Review in Moderate to Severe Plaque Psoriasis., PMID:32207094
• Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy., PMID:33769772
• Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient., PMID:37905433
• Certolizumab pegol for hidradenitis suppurativa: Case report and literature review., PMID:33135826
• Certolizumab pegol for induction of remission in Crohn's disease., PMID:31476018
• ACG Clinical Guideline: Management of Crohn's Disease in Adults., PMID:29610508
• [Certolizumab]., PMID:31208736
• Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation., PMID:27140438
• Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis., PMID:31917928

Примечание

For research use only.

Изображения

Western blot

Western blot analysis was performed using anti-Certolizumab polyclonal antibody at 1ug/mL on recombinant Certolizumab (Catalog No. HF879016).

Ссылки

Даташит

Anti-Certolizumab Polyclonal Antibody.pdf

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Рекомбинантные Белки

Антитела

Наборы для анализа